Marjolijn N. Lub–de Hooge

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

Eli Dijkers, Thijs H. Oude Munnink, Jos G. W. Kosterink et al. · Clinical Pharmacology & Therapeutics · 2010 · 807 citations

Medicine, Nuclear Medicine, Oncology +17

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

Frederike Bensch, Elly L. van der Veen, Marjolijn N. Lub–de Hooge et al. · Nature Medicine · 2018 · 734 citations · Full text

Medicine, Oncology, Pharmacology +17

Development and Characterization of Clinical-Grade ⁸⁹Zr-Trastuzumab for HER2/<i>neu</i> ImmunoPET Imaging

Eli Dijkers, Jos G. W. Kosterink, Anna P. Rademaker et al. · Journal of Nuclear Medicine · 2009 · 337 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft

Wouter B. Nagengast, Elisabeth G.E. de Vries, Geke A.P. Hospers et al. · Journal of Nuclear Medicine · 2007 · 314 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Patrick J. Perik, Marjolijn N. Lub–de Hooge, Jourik A. Gietema et al. · Journal of Clinical Oncology · 2006 · 308 citations · Full text

Medicine, Nuclear Medicine, Oncology +17